Neuroprotective interventions: Is it too late?

Journal of Child Neurology

Volumn 24, Issue 9, 2009, Pages 1212-1219

  Jenkins, Dorothea D ^a   Chang, Eugene ^a   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Hypothermia; Hypoxic ischemic encephalopathy; N acetylcysteine; Neuroprotective

Indexed keywords

ACETYLCYSTEINE; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBRAL PALSY; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE COURSE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; DRUG TARGETING; EARLY INTERVENTION; ENCEPHALITIS; ENCEPHALOMALACIA; ENZYME INDUCTION; HUMAN; HYPOTHERMIA; LATENT PERIOD; MYELINATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; RISK FACTOR;

ACETYLCYSTEINE; ANIMALS; ANIMALS, NEWBORN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; MALE; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; OXIDATIVE STRESS; POLYSACCHARIDES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESEARCH DESIGN; TIME FACTORS;

EID: 70349290983     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073809338412     Document Type: Article

References (63)

1. Iwata O., Iwata S., Bainbridge A., et al. Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: Relation to baseline energetics, insult severity and outcome. Brain. 2008; 131(pt 8): 2220-2226.
2. Lorek A., Takei Y., Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: Continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1994; Dec; 36(6): 699-706.
3. Nedelcu J., Klein MA, Aguzzi A., Boesiger P., Martin E. Biphasic edema after hypoxic ischemic brain injury in neonatal rats reflects early neuronal and late glial damage. Pediatr Res. 1999; 46(3): 297-304.
4. Iwata O., Iwata S., Thornton JS, De Vita E., et al. "Therapeutic time window" duration decreases with increasing severity of cerebral hypoxia-ischaemia under normothermia and delayed hypothermia in newborn piglets. Brain Res. 2007; 1154: 173-180.
5. Penrice J., Lorek A., Cady EB, et al. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet. Pediatr Res. 1997; 41(6): 795-802.
6. Gunn AJ, Bennet L., Gunning MI, Gluckman PD, Gunn TR Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep. Pediatr Res. 1999; 46(3): 274-280.
7. Puka-Sundvall M., Wallin C., Gilland E., Hallin U., Wang X., Sand-berg M., Karlsson J., Blomgren K., Hagberg H. Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury. Brain Res Dev Brain Res. 2000; 125(1-2): 43-50.
8. Nijboer CH, Heijnen CJ, Groenendaal F., May MJ, van Bel F., Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke. 2008; 39(7): 2129-2137.
9. Loddick SA, Turnbull AV, Rothwell NJ Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1998; 18(2): 176-179.
10. Herrmann O., Tarabin V., Suzuki S., et al. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab. 2003; 23(4): 406-415.
11. Suzuki S., Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T., Mihara M., Ohsugi Y., Abe K., Okano H. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem. 2005; 94(2): 459-468.
12. Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 1997; 99(2): 248-256.
13. Gluckman PD, Wyatt JS, Azzopardi D., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet. 2005; 365(9460): 663-670.
14. Yamashita T., Sawamoto K., Suzuki S., et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: Possible involvement of Stat3 activation in the protection of neurons. J Neurochem. 2005; 94(2): 459-468.
15. Pannu R., Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006; 49(2): 170-182.
16. O'Brien FE, Iwata O., Thornton JS, et al. Delayed whole-body cooling to 33 or 35 degrees C and the development of impaired energy generation consequential to transient cerebral hypoxia-ischemia in the newborn piglet. Pediatrics. 2006; 117(5): 1549-1559.
17. Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: Efficacy outcomes. Pediatr Neurol. 2005; 32(2): 11-17.
18. Shankaran S., Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353(15): 1574-1584.
19. Vexler ZS, Sharp FR, Feuerstein GZ, et al. Translational stroke research in the developing brain. Pediatr Neurol. 2006; 34(6): 459-463.
20. Sizonenko SV, Sirimanne E., Mayall Y., et al. Selective cortical alteration after hypoxic-ischemic injury in the very immature rat brain. Pediatr Res. 2003; 54(2): 263-269.
21. Gunn AJ, Bennet L. Brain cooling for preterm infants. Clin Perinatol. 2008; 35(4): 735-748, vi-vii.
22. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intra-amniotic infection. Am J Obstet Gynecol. 1991; 164(5 pt 1): 1317-1326.
23. Kashlan F., Smulian J., Shen-Schwarz S., Anwar M., Hiatt M., Hegyi T. Umbilical vein IL-6 and TNFα plasma concentrations in the very preterm infant. Pediatr Infect Dis J. 2000; 19(3): 238-243.
24. Newton ER Preterm labor, premature rupture of membranes and chorioamnionitis. Clin Perinatology. 2005; 32(3): 571-600.
25. Andrews WW, Hauth JC, Goldenberg RL Infection and preterm birth. Am J Perinatol. 2000; 17(7): 357-365.
26. Alexander JM, Gilstrap LC, Cox S., McIntire DM, Leveno KJ Clinical chorioamnionitis and the prognosis for very low birth weight infants. Ob Gyn. 1998; 91(5 pt 1): 725-729.
27. Inder TE, Wells SJ, Mogridge NB, Spencer C., Volpe JJ Defining the nature of cerebral abnormalities in the premature infant: A qualitative MRI study. J Pediatr. 2003; 143(2): 171-179.
28. Murphy DJ, Sellers S., MacKenzie IZ, Yudkin PL, Johnson AM Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995; 346(8988): 1449-1554.
29. Counsel SJ, Allsop JM, Harrison MC, et al. Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics. 2003; 112(1 pt 1): 1121-1127.
30. Yoon BH, Romero R., Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000; 182(3): 675-681.
31. Miller SP, Cozzio CC, Goldstein RB, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol. 2003; 24(8): 1661-1669.
32. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003; 290(20): 2677-2884.
33. Grether JK, Nelson KB Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 1997; 278(3): 207-211.
34. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000; 284(23): 1417-1424.
35. Kramer BW, Moss TJ, Willet KE, et al. Dose and time response after intra-amniotic endotoxin in preterm lambs. Am J Respir Crit Care Med. 2001; 164(6): 982-988.
36. Martinez E., Figeroa R., Garry D., et al. Elevated amniotic fluid IL-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Matern Fetal Investig. 1998; 8(3): 101-107.
37. Kashlan F., Smulian J., Shen-Schwarz S., Anwar M., Hiatt M., Hegyi T. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J. 2000; 19(3): 238-243.
38. Yoon BH, Romero R., Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma IL-6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000; 183(5): 1124-1129.
39. Nelson KB, Dambrosia JM, Grether JK, Phillips TM Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol. 1998; 44(4): 665-675.
40. Merrill JE TNF-α, IL-1 and related cytokines in brain development: Normal and pathologic. Dev Neurosci. 1992; 14: 1-10.
41. Selmaj KW, Raine CS Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988; 23(4): 339-346.
42. Pang Y., Cai Z., Rhodes PG Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J Neurosci Res. 2005; 80(2): 226-234.
43. Garnier Y., Coumans ABC, Jensen A., Hasaart TH, Berger R. Infection-related perinatal brain injury: The pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investig. 2003; 10(8): 450-459.
44. Eklind S., Mallard C., Arvidsson P., Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res. 2005; 58(1): 112-116.
45. Coumans AB, Middelanis JS, Garnier Y., et al. Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res. 2003; 53(5): 770-775.
46. Eklind S., Hagberg H., Wang X., et al. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr Res. 2006; 60(2): 161-168.
47. Haynes RL, Folkerth RD, Keefe RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003; 62(5): 441-450.
48. Garnier Y., Coumans A., Jensen A., Jensen A., Hasaart TH Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J Soc Gynecol Investig. 2001; 8(3): 134-142.
49. Harris AP, Helou S., Gleason CA, Traystman RJ, Koehler RC Fetal cerebral and peripheral circulatory responses to hypoxia after nitric oxide synthase inhibition. Am J Physiol Regul Integr Comp Physiol. 2001; 281(2): R381-R390.
50. Adamson SL, Whiteley KJ, Langille BL Endothelin-1 constricts fetoplacental microcirculation and decreases fetal O2 consumption in sheep. Am J Physiol. 1996; 270(1 pt 2): H16-H23.
51. Paintlia MK, Paintlia AS, Khan M., Singh I., Singh AK Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem. 2008; 105(3): 956-970.
52. Sheldon RA, Jiang X., Francisco C., et al. Manipulation of antioxidant pathways in neonatal murine brain. Pediatr Res. 2004; 56(4): 656-662.
53. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC Arrested oligodendrocyte lineage progression during human cerebral white matter development: Dissociation between the timing of progenitors differentiation and myelinogenesis. J Neuropathol Exp Neurol. 2002; 61(2): 197-211.
54. Regnault TRH, Marconi AM, Glazier JD, et al. Placental amino acid transport systems and fetal growth restriction: A workshop report. Placenta. 2005; 26(suppl A): S76-S80.
55. Ahola T., Lapatto R., Raivio KO, et al. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: A randomized controlled trial. J Pediatr. 2003; 143(6): 713-719.
56. Paintlia MK, Paintlia AS, Barbosa E., et al. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004; 78(3): 347-361.
57. Farr SA, Poon HF, Dogrukol-Ak D., et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003; 84(5): 1173-1183.
58. Beloosesky R., Gayle DA, Amidi F., et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol. 2006; 194(1): 268-273.
59. Beloosesky R., Gayle DA, Ross MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol. 2006; 195(4): 1053-1057.
60. Wang X., Svedin P., Nie C., et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol. 2007; 61(3): 263-271.
61. Ahola T., Fellman V., Laaksonen R., et al. Pharmacokinetics of intravenous N-acetylcysteine in pre-term newborn infants. Eur J Clin Pharmacol. 1999; 55(9): 645-650.
62. Schmidt LE, Knudsen TT, Dalhoff K., Bendtsen F. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet. 2002; 360(9340): 1151-1152.
63. Perry HE, Shannon MW Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: Results of an open-label, clinical trial. J Pediatr. 1998; 132(1): 149-152.